BIBvsIWM
ProShares Ultra Nasdaq Biotechnology against iShares Russell 2000 ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| BIB | IWM | |
|---|---|---|
| Expense ratio | 0.95% | 0.19% |
| Assets | $96M | $74.2B |
| Net flow, 1 month | +$2M | −$1.3B |
| Net flow, 1 year | −$8M | −$4.1B |
| Return, YTD | +39.2% | +12.5% |
| Return, 1 year | — | — |
| Avg daily volume | 8K | 25.1M |
| Holdings | 229 | 1941 |
| Listed | Apr 9, 2010 | May 22, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS